During the past decade, Center for Dermatology Clinical Research, Inc conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 26 clinical trials were completed, i.e. on average, 55.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 17 clinical trials were completed. i.e. 141.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Dermatology Clinical Research, Inc" #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Pfizer" with 4 trials sponsored, "Stiefel, a GSK Company" with 4 trials sponsored, "Asana BioSciences" with 3 trials sponsored and "Incyte Corporation" with 3 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Dermatology Clinical Research, Inc" #1 collaborator was "Dermira, Inc." with 4 trials as a collaborator, "GlaxoSmithKline" with 4 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator, "Nektar Therapeutics" with 2 trials as a collaborator and "Center for Dermatology Clinical Research, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Center for Dermatology Clinical Research, Inc" are "Atopic Dermatitis" (16 trials), "Acne Vulgaris" (8 trials), "Actinic Keratosis" (7 trials), "Psoriasis" (5 trials) and "Dermatitis, Atopic" (3 trials). Many other conditions were trialed in "Center for Dermatology Clinical Research, Inc" in a lesser frequency.

Most popular intervention types in "Center for Dermatology Clinical Research, Inc" are "Drug" (53 trials), "Biological" (8 trials), "Other" (6 trials), "Device" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Lebrikizumab" (5 trials), "Vehicle" (4 trials), "ASN002" (3 trials) and "Baricitinib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Center for Dermatology Clinical Research, Inc" are 63 trials for "All" genders.

Currently, there are NaN active trials in "Center for Dermatology Clinical Research, Inc". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Center for Dermatology Clinical Research, Inc, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Dermatology Clinical Research, Inc, 4 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".

Center for Dermatology Clinical Research, Inc has several departments that took part in Clinical trials: "Center for Dermatology Clinical Research" - 21 trials